Intracellular protein delivery has been a major challenge in the field of cell biology for decades. Engineering such delivery is a key step in the development of protein- and antibody-based therapeutics. Now, two different approaches that enable the delivery of antibodies and antibody fragments into the cytosol have been developed.
References
Mitragotri, A., Burke, P. A. & Langer, R. Nat. Rev. Drug Discov. 13, 655–672 (2014).
Oller-Salvia, B., Sánchez-Navarro, M., Giralt, E. & Teixidó, M. Chem. Soc. Rev. 45, 4690–4707 (2016).
Singh, R., Singh, S. & Lillard, J. W. Jr J. Pharm. Sci. 97, 2497–2523 (2008).
Schwarze, S. R., Ho, A., Vocero-Akbani, A. & Dowdy, S. F. Science 285, 1569–72 (1999).
Derossi, D., Chassaing, G., Prochiantz, A. et al. Trends Cell Biol. 8, 84–87 (1998).
Virès, E., Granier, C., Prevot, P. & Lebleu, B. Lett. Pept. Sci. 4, 429–436 (1997).
Lundberg, M. & Johansson, M. Biochem. Biophys. J. 29, 367–371 (2002).
Akishiba, M. et al. Nat. Chem. 9, 751–761 (2017).
Herce, H. D. et al. Nat. Chem. 9, 762–771 (2017).
Lättig-Tünnemann, G. et al. Nat. Commun. 2, 453 (2011).
Sánchez-Navarro, M., Garcia, J, Giralt, E. & Teixidó, M. Adv. Drug Delivery Rev. 106, 355–366 (2016).
Rothbauser, U. et al. Nat. Struct. Mol. Biol. 17, 133–138 (2009).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sánchez-Navarro, M., Teixidó, M. & Giralt, E. Just passing through. Nature Chem 9, 727–728 (2017). https://doi.org/10.1038/nchem.2837
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchem.2837
- Springer Nature Limited